Cigna Accounts payable and Accrued expenses and other liabilities decreased by 127.0% to -$988.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.8%, from -$1.17B to -$988.00M. Over 3 years (FY 2021 to FY 2024), Accounts payable and Accrued expenses and other liabilities shows an upward trend with a 145.4% CAGR.
An increase suggests the company is delaying payments to preserve cash, while a decrease indicates faster settlement of liabilities.
This represents the net change in short-term obligations owed to suppliers, service providers, and other operational cre...
Standard across all industries; peers in healthcare services often show fluctuations based on PBM contract cycles.
operating_increase_decrease_in_accounts_payable_accrued__b705b6| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$1.01B | $232.00M | $1.49B | $85.00M | -$119.00M | $414.00M | $1.35B | $690.00M | $0.00 | $699.00M | $2.14B | -$1.07B | $1.05B | -$804.00M | $1.96B | -$1.17B | $3.65B | -$988.00M |
| QoQ Change | — | +123.1% | +541.4% | -94.3% | -240.0% | +447.9% | +227.1% | -49.0% | -100.0% | — | +206.7% | -149.8% | +198.6% | -176.4% | +343.4% | -160.0% | +411.2% | -127.0% |
| YoY Change | — | — | — | — | +88.2% | +78.4% | -9.0% | +711.8% | +100.0% | +68.8% | +58.3% | -254.8% | — | -215.0% | -8.7% | -9.9% | +86.7% | +15.8% |